Home
Conditions
Solid Tumor

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

716 public trials 251 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumor trial results

Active, Not Recruiting

Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

NCT05379946

Conditions: Solid Tumor
Locations: Zhejiang Cancer Hospital, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China

View Trial Details

Active, Not Recruiting

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

NCT06166836

Conditions: Solid Tumor
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

First Affiliated Hospital of Bengbu Medical College Bengbu, China

Hunan Cancer Hospital Changsha, China

Fujian Cancer Hospital Fuzhou, China

View Trial Details

Active, Not Recruiting

A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors

NCT05672459

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

NCT03872947

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +58 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

AOA-HOPE Tucson, Arizona, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

HOAG Memorial Hospital Presbyterian Newport, California, United States

View all 14 locations

View Trial Details

Active, Not Recruiting

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

NCT03991832

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors

NCT04503278

Conditions: Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +35 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

Charité - Universitätsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany

Universitätsklinikum Köln AÖR-Centrum für Integrierte Onkologie (CIO)-Studienzentrum der Klinik I für Innere Medizin (CTU Cologne) Cologne, Germany

Universitätsklinikum Erlangen - Hämatologie & Intrinsische Onkologie - Medizinische Klinik 5 Erlangen, Germany

View Trial Details

Active, Not Recruiting

A Study of Avutometinib for People With Solid Tumor Cancers

NCT06104488

Conditions: Brain Diseases, Brain Neoplasms, CNS Tumor, Adult, +34 more
Locations: Children's Healthcare of Atlanta (Data Collection Only) Atlanta, Georgia, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Active, Not Recruiting

Characterizing Sleep Among Long-term Survivors of Childhood Cancer

NCT05480904

Conditions: ALL, Adult, CNS Tumor, Central Nervous System Neoplasms, +15 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

NCT03006172

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Massachusetts General Hospital. Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

Columbia University Medical Center New York, United States

View all 13 locations

View Trial Details

Active, Not Recruiting

Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations

NCT03839342

Conditions: Solid Tumor
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Solid Tumor

Solid Tumor trial results

Related conditions